Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.40
Delayed Data
As of Jul 25
 -0.05 / -2.04%
Today’s Change
1.65
Today|||52-Week Range
5.70
+37.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues7.8M7.0M13.9M19.1M
 
 
 
 
 
Cost of Goods Sold1.8M1.8M4.2M6.1M
 
 
 
 
 
Depreciation And Amortization116.0K1.5M2.0M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income5.9M3.7M7.7M11.0M
 
 
 
 
 
General Expenses39.1M40.4M48.7M63.4M
 
 
 
 
 
Research And Development14.2M5.3M6.7M8.2M
 
 
 
 
 
Total Operating Expenses41.0M43.7M54.8M71.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.2M-36.7M-40.9M-52.4M
 
 
 
 
 
Extraordinary Credit11.6M86.3M26.0M12.3M
 
 
 
 
 
Extraordinary Charge0.00-1.0M-2.0M-29.4M
 
 
 
 
Interest Expense On Debt2.0M2.0M2.0M1.2M
 
 
 
 
 
Other Expenses-1.8M786.0K-5.6M1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.2M47.7M-24.5M-69.1M
 
 
 
 
 
Income Taxes0.000.00-133.0K0.00
 
 
Net Income-25.2M47.7M-24.6M-69.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.6M14.6M14.6M14.8M
 
 
 
 
 
Shares To Calculate EPS Diluted14.6M36.6M14.6M14.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$17.30$1.12-$1.69-$4.67
 
 
 
 
 
EPS Diluted-$1.73$1.12-$1.69-$4.67